Author Archives: admin


3 business updates to know on Williams Field Road in Gilbert – Community Impact Newspaper

The Sonoran Desert Olive Oil Co. opened a store in SanTan Village in November. (Tom Blodgett/Community Impact Newspaper)

NOW OPEN

A second location of the Sonoran Desert Olive Oil Company opened Nov. 18 in SanTan Village at 2206 E. Williams Field Road, Ste. 104, Gilbert. The store offers a selection of balsamic vinegars and olive oils sourced from all over the world. It also has olive leaf teas. The company's first location is in Phoenix. 480-656-9076. http://www.sonorandesertoliveoil.com

COMING SOON

Nascent Health anticipates opening a wellness clinic at 115 E. Williams Field Road, Ste. 101, Gilbert, some time in January. Its services include injections, IV therapies, microneedling, platelet rich plasma and regenerative therapies. 480-270-8318. http://nascenthealthclinics.com

ANNIVERSARIES

Donaldson Watches and Repair is celebrating its 10th anniversary at 1464 E. Williams Field Road, Ste. 103, Gilbert. The shops anniversary actually fell in March, but the company postponed marking it until after it reopened following COVID-19-related closures. 480-855-0839. http://www.donaldsonwatchrepair.com

The rest is here:
3 business updates to know on Williams Field Road in Gilbert - Community Impact Newspaper

Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021

BERKELEY HEIGHTS, N.J., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that the Company will present at Biotech Showcase™ Digital 2021. The conference is taking place online between January 11-15 and will feature prerecorded sessions of company presentations. Spiro Rombotis, President & Chief Executive Officer, will provide an overview of the Company and progress in key programs.

The rest is here:
Cyclacel Pharmaceuticals to Present at Biotech Showcase™ Digital 2021

Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B

GAITHERSBURG, Md., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has enrolled the first patient in its multinational Phase 2 clinical trial of HepTcell, a novel peptide-based immunotherapeutic under development for treatment of chronic hepatitis B (CHB).

Visit link:
Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B

TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab…

NDA was Submitted in November in the Indication of MSI-H/dMMR Cancer, Including Colorectal and Gastric Cancer NDA was Submitted in November in the Indication of MSI-H/dMMR Cancer, Including Colorectal and Gastric Cancer

Original post:
TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab...